Search results

Found 150 pages
AUTHOR: PharmaTimes Reporter

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

Pfizer strikes gene therapy deal with Sangamo

Says one of the candidates included has best-in-class potential - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/pfizer_strikes_gene_therapy_deal_with_sangamo_1192766

UK life sciences financing on the up

There has been a resurgence in life sciences financing in the UK, amounting to $2.86 billion, new figures reveal.  - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/uk_life_sciences_financing_on_the_up_971188

Takeda establishes new drug discovery subsidiary

Also transfers part of its pharmaceutical sciences businesses to Bushu - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/takeda_establishes_new_drug_discovery_subsidiary_1192847

Risk specialists arrested in China

A husband and wife corporate investigation team that have reportedly worked for GlaxoSmithKline have been arrested in China. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/risk_specialists_arrested_in_china_1005582

Video surveillance could support dementia patients

But consent would be key for the use of home camera-based systems - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/video_surveillance_could_support_dementia_patients_1193020

Gilead-backed Hep B vaccine fails

GlobeImmune and partner Gilead suffered a setback this week after its new hepatitis B vaccine GS-4774 missed its mid-stage trial target. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/gilead-backed_hep_b_vaccine_fails_971449

FDA approves Salix and Actavis IBS drugs

Two new treatments for irritable bowel syndrome (IBS) have been approved by the US Food and Drug Administration. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/fda_approves_salix_and_actavis_ibs_drugs_971451

Teva gets EU nod for Neulasta 'biobetter'

Teva has chalked up a milestone in its branded products business after winning EU approval for Lonquex, a white blood cell stimulator that will compete with Amgen's blockbuster Neulasta brand. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/teva_gets_eu_nod_for_neulasta_biobetter_1005530

Latest jobs from #PharmaRole

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download